Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000427844 | SCV000521559 | benign | not specified | 2016-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001000007 | SCV000602385 | benign | Combined malonic and methylmalonic acidemia | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001000007 | SCV000771503 | benign | Combined malonic and methylmalonic acidemia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000427844 | SCV002051040 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528491 | SCV004138205 | benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | ACSF3: BP4, BS1, BS2 |
Natera, |
RCV001000007 | SCV001457754 | benign | Combined malonic and methylmalonic acidemia | 2020-06-02 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001528491 | SCV001740316 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000427844 | SCV001929621 | benign | not specified | no assertion criteria provided | clinical testing |